Stem Cell Biology Articles & Analysis
11 news found
Rizo served in a number of oncology drug development functions with increasing responsibilities at Janssen Research and Development, LLC (Janssen), including Senior Director, Compound Development Team Leader for all myeloid assets, Senior Director, Global Clinical Leader for the imetelstat, ibrutinib mantle cell lymphoma (MCL) program, and others. In these roles, she had ...
ByBayer AG
TreeFrog Therapeutics, a biotechnology company aimed at making safer, more efficient and more affordable cell therapies based on induced pluripotent stem cells (iPSCs), today announced the launch of The Stem Cell SpaceShot Grant, a $100,000 research funding in the field of stem ...
Melissa Carpenter, PhD, Chief Scientific Officer, ElevateBio, Regenerative Medicine Author of over 50 peer-reviewed articles and inventor of 34 issued patents, Melissa Carpenter has been pioneering the field of stem cell-derived cell therapies for the past 25 years. She started her career at CytoTherapeutics (became StemCells, Inc), where she ...
Sewall Professor, Stanford University School of Medicine, Department of Otolaryngology – Head & Neck Surgery and Institute for Stem Cell Biology and Regenerative Medicine ISCBRM. “We are excited to announce this new, internally-developed initiative for Lineage, and to do it so quickly following the partnership we announced with ...
Tiago Fleming Outeiro, PhD received his PhD in Molecular and Cell Biology at the Whitehead Institute for Biomedical Research, MIT, and the University of Chicago. ...
InGeneron, Inc., a clinical stage biotechnology company, announced the publication of a succinct scientific review of regenerative cell therapy, commonly called “stem cell therapy”, to treat orthopedic indications. ...
Dr. Jeanne Loring, Professor Emeritus of The Scripps Research Institute, Founding Director of the Center for Regenerative Medicine at Scripps, and founder of Aspen Neuroscience, has joined the Scientific Advisory Board of StemBioSys, Inc., (SBS) a privately-held, San Antonio-based biomedical company focused on a broad range of cell-based products. StemBioSys CEO Bob Hutchens made the ...
This is the first trial in the United States to study pluripotent stem cell-derived dopaminergic neurons in patients with Parkinson’s disease. ...
Parma and Modena, 16 June 2020 – Chiesi Farmaceutici, international research-focussed group (Chiesi Group), and Holostem Terapie Avanzate, top Italian biotech company entirely dedicated to the development, production, registration and distribution of medicinal products for advanced therapies, announce the signing of a contract for the transfer of the business branch of Holoclar®, an ...
Hypoxia maintains the niche where stem cells stay in optimal condition that benefits the self-renewal capacities of human embryonic, mesenchymal, hematopoietic and neural stem cells. In research setting it is very important to understand that the results of any given experiment are only as good as the methods they were produced ...
ByBaker
Regenerative medicine is the use of tissue engineering and molecular biology to improve or replace biological function in human cells, tissues and organs. Research on adult stem cells has generated a great deal of excitement in this regard. Despite the challenges in understanding adult stem ...